Close Menu

Books in a Library

K Demirdağ

Investigation by the Method of INNO-LiPA of Primary Resistance to Lamivudine in Patients with Chronic Hepatitis B Who Have Not Used Antiviral Therapy

Issue: 
DOI: 
10.7727/wimj.2014.291
Pages: 
111–5
Synopsis: 
Lamivudine, an effective oral antiviral agent, inhibits the replication of hepatitis B virus by blocking reverse transcriptase enzyme. Administering lamivudine is an effective and convenient method of early treatment.

ABSTRACT

Accepted: 
29 Oct, 2014
PDF Attachment: 
Journal Sections: 
e-Published: 30 Apr, 2015
Subscribe to RSS - K Demirdağ
Top of Page